A little less pressure around skin.
You do not have to treat your skin as a problem to be curious about these ingredients and the evidence.
The same care applies to words. “Glow” and “anti-aging” can carry large expectations. A treatment group’s name does not establish that a product changes skin or slows aging. The evidence needs to answer a more specific question.
Follow the form, not just the name.
GHK-Cu is a small peptide bound to copper. A peptide is a chain of amino acids, the building blocks of proteins. In skincare, GHK-Cu is often called Copper Tripeptide-1.
A topical product is placed on the skin. An injectable preparation is a different form with different safety questions. Small studies of creams cannot show what happens after an injection. Laboratory work on skin cells is a different setting again.
Approval stays specific.
No medicine containing GHK-Cu has FDA approval. Cosmetics and medicines follow different rules; seeing an ingredient in a serum does not establish approval of an injection. Compounded GHK-Cu is not FDA-approved.
The FDA’s page current as of April 22, 2026, lists injectable GHK-Cu as “nominated but withdrawn.” The withdrawn nomination is not FDA clearance or approval. Non-injected forms have a separate compounding-list history. It matters which form a sentence is about.
Let the conversation be personal.
Promise groups these consultations under anti-aging and longevity. That name does not establish what a treatment will do. A licensed U.S. provider reviews every request and decides whether a prescription is appropriate. Not everyone qualifies.
- Is this a cosmetic question or a prescription question?
- Does the human research test this exact form?
- What is known about safety, and what is not?
- What other options fit the concern I am describing?
A pharmacy separately decides whether it can lawfully prepare a compounded prescription. Compounded medicines are not FDA-approved. A welcoming page and a licensed review have different jobs.